bioRxiv ScienceSearch

bioRxiv · 10.1101/532200

Spatio-temporal structure of single neuron subthalamic activity in Tourette Syndrome explored during DBS procedures

Abstract

Basal ganglia dysfunctions have been suggested to play a causal role in the pathophysiology of most motor and non-motor symptoms of movement disorders as Tourette Syndrome (TS) or Parkinsons Disease (PD). Intra/post-operative recordings from the subthalamic nucleus (STN) during Deep Brain Stimulation (DBS) procedures in PD patients have highlighted specific pathological patterns of neural activity. Spatial and temporal patterns of STN neural activity in TS are still unknown due to the lack of direct microrecordings in humans. Here, we describe for the first time specific neural activities of sensorimotor STN in TS patients, as recorded during intraoperative microrecordings. We analyzed 125 single units at 0.5 mm-spaced depths from the STN of anesthetized TS patients and we observed a large fraction of units (39/125, 31.2%) intensely bursting in the delta band (<4 Hz). In anesthetized PD patients we found similar average firing rate and spectral density of STN units, but differently to TS patients, only 4/54 (7.4%) of the units displayed bursting. Remarkably, bursting units in TS STN were not homogeneously distributed over the dorso-ventral trajectory of the recording: the highest density of bursting units was reliably found at the depth for which the clinical effect was maximal. Our results provide an unprecedented characterization of STN functional architecture and single units dynamics in TS patients, paving the way to an understanding of the role of STN subterritories in TS. Key PointsO_LISingle neuron activity in Subthalamic Nucleus (STN) of patients with Tourette Syndrome (TS) was analyzed for the first time in literature. C_LIO_LIFiring rate and spectral content of single STN neurons in TS patients were found to be similar to those of anesthetized PD patients, while the analysis of arrhythmic bursting activity revealed that in TS patients the STN is characterized by a larger fraction of bursting neurons and more intense bursts C_LIO_LIBursting activity in TS was widespread across the whole STN, but with a higher density at the optimal lead location depth for DBS C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vissani, M., Cordella, R., Micera, S., Romito, L. M., Mazzoni, A.. 2019-01-28. Spatio-temporal structure of single neuron subthalamic activity in Tourette Syndrome explored during DBS procedures. https://doi.org/10.1101/532200

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience